| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
36,440,000 |
| Market
Cap: |
347.64(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$9.54 - $9.54 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile SeaSpine Holdings is a medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. Co. has a portfolio of orthobiologics and spinal implant solutions, as well as a surgical navigation system to perform fusion procedures in the lumbar, thoracic and cervical spine. Co.'s orthobiologics products consist of a range of bone graft substitutes including spine, hip, and extremities procedures. Co.'s spinal implants portfolio consists of a line of products and image-guided surgical solutions to help spinal fusion in degenerative, minimally invasive surgery, and spinal deformity procedures.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
53,786 |
| Total Sell Value |
$0 |
$0 |
$0 |
$316,788 |
| Total People Sold |
0 |
0 |
0 |
2 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lipschultz Tyler |
SVP, Orthobiologics and BD |
• – – |
2022-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,926 |
124,393 |
|
- |
|
| Valentine Keith |
Chief Executive Officer |
• • – |
2022-01-01 |
4 |
D |
$13.62 |
$152,095 |
D/D |
(11,167) |
314,001 |
|
- |
|
| Valentine Keith |
Chief Executive Officer |
• • – |
2022-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,972 |
325,168 |
|
- |
|
| Winge John J. |
Vice President, Sales |
• – – |
2021-12-31 |
4 |
A |
$11.58 |
$6,033 |
D/D |
521 |
77,910 |
|
- |
|
| Valentine Keith |
Chief Executive Officer |
• • – |
2021-12-31 |
4 |
A |
$8.92 |
$9,152 |
D/D |
1,026 |
305,196 |
|
- |
|
| Steinway Angela |
Director |
– • – |
2021-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
7,782 |
7,782 |
|
- |
|
| Bradley Keith |
Director |
– • – |
2021-12-02 |
4 |
D |
$13.38 |
$495 |
D/D |
(37) |
73,005 |
|
- |
|
| Bradley Keith |
Director |
– • – |
2021-09-02 |
4 |
D |
$16.95 |
$627 |
D/D |
(37) |
73,042 |
|
- |
|
| Fekete Michael |
Director |
– • – |
2021-08-20 |
4 |
B |
$14.80 |
$148,000 |
D/D |
10,000 |
88,370 |
2.39 |
-10% |
|
| Standish Beau |
President, Enabling Tech |
• – – |
2021-07-21 |
4 |
AS |
$19.24 |
$194,339 |
D/D |
(10,100) |
0 |
|
-31% |
|
| Standish Beau |
President, Enabling Tech |
• – – |
2021-07-16 |
4 |
AS |
$19.24 |
$154,932 |
D/D |
(8,054) |
10,100 |
|
-21% |
|
| Standish Beau |
President, Enabling Tech |
• – – |
2021-07-15 |
4 |
AS |
$18.83 |
$341,865 |
D/D |
(18,154) |
18,154 |
|
-24% |
|
| Cirino Dennis |
SVP, Global Spinal Systems |
• – – |
2021-07-02 |
4 |
D |
$20.23 |
$92,390 |
D/D |
(4,567) |
37,545 |
|
- |
|
| Cirino Dennis |
SVP, Global Spinal Systems |
• – – |
2021-07-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,207 |
42,112 |
|
- |
|
| Essig Stuart |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,097 |
444,332 |
|
- |
|
| Valentine Keith |
Chief Executive Officer |
• • – |
2021-06-30 |
4 |
A |
$8.92 |
$12,096 |
D/D |
1,356 |
304,170 |
|
- |
|
| Cirino Dennis |
SVP, Global Spinal Systems |
• – – |
2021-06-30 |
4 |
A |
$8.92 |
$21,256 |
D/D |
2,383 |
28,905 |
|
- |
|
| Lipschultz Tyler |
SVP, Orthobiologics and BD |
• – – |
2021-06-30 |
4 |
A |
$8.92 |
$21,256 |
D/D |
2,383 |
112,467 |
|
- |
|
| Stephenson Kirtley C. |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
914 |
106,319 |
|
- |
|
| Gaeta Renee |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
609 |
26,113 |
|
- |
|
| Bradley Keith |
Director |
– • – |
2021-06-30 |
4 |
D |
$20.51 |
$738 |
D/D |
(36) |
73,079 |
|
- |
|
| Bradley Keith |
Director |
– • – |
2021-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
792 |
73,115 |
|
- |
|
| Bradley Keith |
Director |
– • – |
2021-06-03 |
4 |
D |
$20.28 |
$7,747 |
D/D |
(382) |
72,323 |
|
- |
|
| Standish Beau |
President, Enabling TechOffice |
• – – |
2021-06-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
36,308 |
|
-23% |
|
| Bradley Keith |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
9,504 |
72,705 |
|
- |
|
328 Records found
|
|
Page 4 of 14 |
|
|
